{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T15:40:10Z","timestamp":1754062810122,"version":"3.41.2"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":103,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.ctarc.2025.100930","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T12:11:41Z","timestamp":1745928701000},"page":"100930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comparative effectiveness of different chemotherapies given to Nodular Lymphocyte Predominant Hodgkin Lymphoma patients: A retrospective study from Lahore, Pakistan"],"prefix":"10.1016","volume":"43","author":[{"given":"Namra","family":"Jabeen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazia","family":"Kanwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haroon","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aamir","family":"Amin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2025.100930_bib0001","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00277-015-2578-6","article-title":"A 20-year population-based study on the epidemiology, clinical features, treatment, and outcome of nodular lymphocyte predominant Hodgkin lymphoma","volume":"95","author":"Strobbe","year":"2016","journal-title":"Ann. Hematol."},{"issue":"26","key":"10.1016\/j.ctarc.2025.100930_bib0002","first-page":"2365","article-title":"Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: a multi-institutional study of adult patients by ILROG. Blood","volume":"135","author":"Binkley","year":"2020","journal-title":"J. American Soc. Hematol"},{"issue":"3","key":"10.1016\/j.ctarc.2025.100930_bib0003","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/cncr.24819","article-title":"Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study Group","volume":"116","author":"Biasoli","year":"2010","journal-title":"Cancer: Interdisciplinary Int. J. American Cancer Soc"},{"issue":"12","key":"10.1016\/j.ctarc.2025.100930_bib0004","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3324\/haematol.2015.133025","article-title":"Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study","volume":"100","author":"Lazarovici","year":"2015","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.ctarc.2025.100930_bib0005","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1200\/JCO.19.00986","article-title":"Long-term follow-up of patients with nodular lymphocyte-predominant Hodgkin lymphoma treated in the HD7 to HD15 trials: a report from the German Hodgkin Study Group","volume":"38","author":"Eichenauer","year":"2020","journal-title":"J. Clinical Oncol"},{"issue":"3","key":"10.1016\/j.ctarc.2025.100930_bib0006","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1200\/JCO.2007.11.8869","article-title":"Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group","volume":"26","author":"Nogov\u00e1","year":"2008","journal-title":"J. Clinic. Oncol"},{"issue":"20","key":"10.1016\/j.ctarc.2025.100930_bib0007","first-page":"2121","article-title":"Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma. Blood","volume":"133","author":"Borchmann","year":"2019","journal-title":"The J. American Soc. Hematol"},{"issue":"10","key":"10.1016\/j.ctarc.2025.100930_bib0008","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1093\/annonc\/mdi323","article-title":"Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG)","volume":"16","author":"Nogova","year":"2005","journal-title":"Annal. Oncol."},{"issue":"4","key":"10.1016\/j.ctarc.2025.100930_bib0009","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/cam4.1383","article-title":"Adult nodular lymphocyte-predominant Hodgkin lymphoma: treatment modality utilization and survival","volume":"7","author":"Alonso","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.ctarc.2025.100930_bib0010","doi-asserted-by":"crossref","first-page":"iv19","DOI":"10.1093\/annonc\/mdy080","article-title":"Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Eichenauer","year":"2018","journal-title":"Annals Oncol"},{"key":"10.1016\/j.ctarc.2025.100930_bib0011","doi-asserted-by":"crossref","unstructured":"Gerber NK, Atoria CL, Elkin EB, Yahalom J. Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis. Int. J. Radiation Oncology* Biology* Physics. 2015;92(1):76-83.","DOI":"10.1016\/j.ijrobp.2015.02.012"},{"issue":"2","key":"10.1016\/j.ctarc.2025.100930_bib0012","doi-asserted-by":"crossref","first-page":"599","DOI":"10.51253\/pafmj.v72i2.3615","article-title":"Nodular Lymphocytic Predominant Hodgkin Lymphoma (NLPHL); Treatment Outcome Study in a Tertiary Care Cancer Hospital in Pakistan: Nodular Lymphocytic Predo-Minant Hodgkin Lymphoma","volume":"72","author":"Shah","year":"2022","journal-title":"Pakistan Armed Forces Med. J"},{"issue":"21","key":"10.1016\/j.ctarc.2025.100930_bib0013","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1182\/blood.V116.21.2812.2812","article-title":"Outcomes of Nodular Lymphocyte Predominant Hodgkin's Lymphoma (NLPHL) Patients Treated with R-CHOP","volume":"116","author":"Fanale","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ctarc.2025.100930_bib0014","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/cncr.24819","article-title":"Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study Group","volume":"116","author":"Biasoli","year":"2010","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.ctarc.2025.100930_bib0015","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1200\/JCO.19.00986","article-title":"Long-term follow-up of patients with nodular lymphocyte-predominant Hodgkin lymphoma treated in the HD7 to HD15 trials: a report from the German Hodgkin Study Group","volume":"38","author":"Eichenauer","year":"2020","journal-title":"J. Clinical Oncol"},{"issue":"1","key":"10.1016\/j.ctarc.2025.100930_bib0016","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-41550-2","article-title":"Targeting transforming growth factor beta (TGF-\u03b2) using Pirfenidone, a potential repurposing therapeutic strategy in colorectal cancer","volume":"13","author":"Jamialahmadi","year":"2023","journal-title":"Sci. Rep."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246829422500067X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246829422500067X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T15:10:53Z","timestamp":1754061053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246829422500067X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":16,"alternative-id":["S246829422500067X"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.100930","relation":{},"ISSN":["2468-2942"],"issn-type":[{"type":"print","value":"2468-2942"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative effectiveness of different chemotherapies given to Nodular Lymphocyte Predominant Hodgkin Lymphoma patients: A retrospective study from Lahore, Pakistan","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.100930","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100930"}}